Regulatory Novo Nordisk comeback stirs as Wegovy pill wins UK approval Pharmaceutical TechnologyThere are already lengthy patient waitlists for the medication on digital health platforms.Metabolic & GLP-1Read full story pharminent June 12, 2026 (Last updated: June 12, 2026) Pharmaceutical Technology There are already lengthy patient waitlists for the medication on digital health platforms. Metabolic & GLP-1 Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: China’s NMPA approves Akeso’s gumokimab for plaque psoriasisNext: Novartis’ $12B Avidity buy pays dividends with Phase 1/2 muscular dystrophy win Related Stories Regulatory Outlook Therapeutics Secures FDA Approval for LYTENAVA pharminent July 31, 2026 Regulatory Outlook finally claims FDA approval for AMD drug pharminent July 27, 2026 Regulatory Outlook Therapeutics wins FDA approval for Lytenava in wet AMD pharminent July 27, 2026
